Medtronic (MDT): FY25 Q4 earnings call, May 21, 2025

Wed, May 21Earnings callSpeaker-labelled transcriptMedtronic

No Kalshi or Polymarket word markets were listed for Medtronic’s May 21, 2025 earnings call (FY25 Q4). The transcript is searchable below (quotes of at most 25 words).

Updated

Transcript

quotes of at most 25 words

Speaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.

7 matches for “Simplera”; 5 quoted, at least 25 words apart.

Geoff Marthacompanyprepared

…achieve more control with less burden. In Europe, the launch of our Simplera Sync sensor is driving strong mid-teen CGM growth. Simplera is half the…

Thierry Pietoncompanyprepared

…from Diabetes as we are early in the manufacturing ramp of the Simplera sensor. We will continue to drive pricing discipline, in particular on the…

Thierry Pietoncompanyqa

…pressure on diabetes, I think it's primarily driven by the rollout of Simplera. So, it's the launch of this product. And as we grow it,…

Que Dallaracompanyqa

…for the question. So, if I start with a recent approval of Simplera Sync in the US, we're ramping that, we're going to be launching…

Que Dallaracompanyqa

…year. So, we have not really begun to see the potential of Simplera on the business yet. Then we have submitted for an ACE pump…

Agents: this page as TSV at /api/v1/appearances/medtronic:2025-05-21:earnings_call · words: /api/v1/brief?appearance=medtronic:2025-05-21:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP